• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAUSCH + LOMB ENVISTA INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAUSCH + LOMB ENVISTA INTRAOCULAR LENS Back to Search Results
Model Number MX60P
Device Problem Scratched Material (3020)
Patient Problem Unspecified Eye / Vision Problem (4471)
Event Date 02/23/2021
Event Type  Injury  
Manufacturer Narrative
Though requested from the reporter, the device was not returned for evaluation.The device history record (dhr) was reviewed and there were no discrepancies or deviations found that related to the reported issue.The lot history, trend analysis, risk analysis, and directions for use are considered acceptable with the product performing within anticipated rates.The most probable root cause is operational context.User related factors (such as loading or handling techniques) and/or procedural factors (such as lens and inserter interaction) might have contributed to the event.On (b)(6) 2021, bausch + lomb received an email from (b)(6) at cdrh/food and drug administration notifying the company that the report initially submitted on (b)(6) 2021 failed in the emdr system with an error due to the presence of the ¿}¿ character as part of the c-code value.There was no ack3 error message which notifies the company that the submission was rejected due to the character.The special character (¿}¿) has been removed and this report is being resubmitted.
 
Event Description
It was reported after an intraocular lens (iol) was implanted into the right (od) eye, the surgeon noticed a scratch at the center of the optic.The incision was enlarged to 3.0mm to explant the iol.A back up iol of the same model and diopter power was successfully implanted intraoperatively.Two sutures were used.The patient did not notice a decrease in vision.In the surgeon's opinion, the most likely cause of the event is due to folding/unfolding of the lens, however the surgeon indicated there was no difficulty in loading or injecting the lens.The patient's outcome is good.
 
Manufacturer Narrative
The product was returned for evaluation.The lens was in a dried condition.Particulates, saline dendrites and dried solutions were visible on the optic.Visual inspection found the lens was cut or torn into two pieces.One haptic was attached to each piece of the optic.Microscopic examination was performed and found a scratch across the optic.The cause of the damage could not be determined.Functional testing could not be performed due to the damage.Our previous conclusions remain unchanged.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENVISTA INTRAOCULAR LENS
Type of Device
INTRAOCULAR LENS
Manufacturer (Section D)
BAUSCH + LOMB
1400 north goodman street
rochester NY 14609
MDR Report Key11592437
MDR Text Key243128787
Report Number0001313525-2021-00043
Device Sequence Number1
Product Code HQL
Combination Product (y/n)Y
PMA/PMN Number
P910056
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,user facility
Type of Report Initial,Followup
Report Date 02/24/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/28/2023
Device Model NumberMX60P
Device Catalogue NumberMX60P1300
Device Lot Number222
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/03/2021
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 02/24/2021
Initial Date FDA Received03/30/2021
Supplement Dates Manufacturer Received05/03/2021
Supplement Dates FDA Received05/28/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
BLIS INJECTOR, AMVISC PLUS VISCOELASTIC
Patient Outcome(s) Required Intervention;
-
-